Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2016
Headcount
6
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
IOIV is a novel additive solution for extending the shelf life of packed red blood cells, while preserving their quality. The product is easy to use, minimizes the wastage of expired blood donations and maximizes the quality of transfused blood. IOIV combines both profitable and lifesaving concepts in one improved and simple product.
Q&A
- What is IOIV's primary focus?
- IOIV is focused on developing a novel additive solution to extend the shelf life of packed red blood cells while preserving their quality.
- When was IOIV founded?
- IOIV was founded in January 2016.
- What is the current status of IOIV?
- IOIV is currently inactive, as of September 2018.
- Where is IOIV headquartered?
- IOIV is headquartered in Haifa, North District, Israel.
- Who are the co-founders of IOIV?
- The co-founders of IOIV are Tom Givaty Katz, Tal Ofek, Rawan Omar, and Sofia Arshavsky-Graham.
- What industry sector does IOIV operate in?
- IOIV operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What are the target customers for IOIV's product?
- IOIV targets customers in Healthcare & Life Sciences, including Healthcare Providers and the Medical Devices Industry for Medical Products.
Team · 4
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Products
Business model
B2B
Tags
stealthmodepharmaceuticalsmedical-products
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2016-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Sep 2018 |